BNP Paribas Financial Markets’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $130M | Sell |
262,258
-153,367
| -37% | -$68M | 0.05% | 359 |
|
|
2026
Q1 | $186M | Sell |
415,625
-143,918
| -26% | -$67.1M | 0.09% | 226 |
|
|
2025
Q4 | $254M | Buy |
559,543
+305,200
| +120% | +$132M | 0.11% | 162 |
|
|
2025
Q3 | $99.6M | Sell |
254,343
-276,845
| -52% | -$116M | 0.05% | 370 |
|
|
2025
Q2 | $236M | Sell |
531,188
-57,149
| -10% | -$26.3M | 0.14% | 130 |
|
|
2025
Q1 | $285M | Sell |
588,337
-8,218
| -1% | -$3.83M | 0.17% | 121 |
|
|
2024
Q4 | $240M | Buy |
596,555
+153,786
| +35% | +$71.3M | 0.13% | 135 |
|
|
2024
Q3 | $206M | Sell |
442,769
-86,116
| -16% | -$41.4M | 0.14% | 150 |
|
|
2024
Q2 | $248M | Buy |
528,885
+8,848
| +2% | +$3.84M | 0.2% | 103 |
|
|
2024
Q1 | $217M | Buy |
520,037
+127,643
| +33% | +$54M | 0.19% | 110 |
|
|
2023
Q4 | $160M | Buy |
392,394
+85,924
| +28% | +$31.7M | 0.18% | 118 |
|
|
2023
Q3 | $107M | Sell |
306,470
-62,001
| -17% | -$21.7M | 0.14% | 155 |
|
|
2023
Q2 | $130M | Buy |
368,471
+89,387
| +32% | +$30.1M | 0.16% | 126 |
|
|
2023
Q1 | $87.9M | Buy |
279,084
+30,763
| +12% | +$9.23M | 0.12% | 164 |
|
|
2022
Q4 | $71.7M | Buy |
248,321
+60,914
| +33% | +$18.6M | 0.11% | 213 |
|
|
2022
Q3 | $54.3M | Sell |
187,407
-110,531
| -37% | -$31.8M | 0.09% | 259 |
|
|
2022
Q2 | $84M | Buy |
297,938
+29,469
| +11% | +$7.89M | 0.13% | 168 |
|
|
2022
Q1 | $70.1M | Buy |
268,469
+98,344
| +58% | +$23.3M | 0.09% | 216 |
|
|
2021
Q4 | $37.4M | Buy |
170,125
+43,429
| +34% | +$8.44M | 0.05% | 392 |
|
|
2021
Q3 | $23M | Sell |
126,696
-41,824
| -25% | -$8.17M | 0.03% | 547 |
|
|
2021
Q2 | $34M | Sell |
168,520
-171,819
| -50% | -$35.9M | 0.05% | 437 |
|
|
2021
Q1 | $73.1M | Buy |
340,339
+154,204
| +83% | +$33.9M | 0.11% | 204 |
|
|
2020
Q4 | $44M | Sell |
186,135
-48,941
| -21% | -$11.2M | 0.08% | 239 |
|
|
2020
Q3 | $64M | Buy |
235,076
+42,195
| +22% | +$11.6M | 0.09% | 217 |
|
|
2020
Q2 | $56M | Buy |
192,881
+75,473
| +64% | +$20.5M | 0.1% | 187 |
|
|
2020
Q1 | $27.9M | Buy |
117,408
+27,485
| +31% | +$6.3M | 0.06% | 305 |
|
|
2019
Q4 | $19.7M | Sell |
89,923
-16,551
| -16% | -$3.35M | 0.04% | 502 |
|
|
2019
Q3 | $18M | Sell |
106,474
-59,893
| -36% | -$10.6M | 0.03% | 517 |
|
|
2019
Q2 | $30.5M | Sell |
166,367
-18,903
| -10% | -$3.3M | 0.06% | 334 |
|
|
2019
Q1 | $34.1M | Buy |
185,270
+119,017
| +180% | +$22M | 0.07% | 289 |
|
|
2018
Q4 | $11M | Sell |
66,253
-86,742
| -57% | -$15M | 0.03% | 598 |
|
|
2018
Q3 | $29.5M | Sell |
152,995
-12,669
| -8% | -$2.26M | 0.04% | 413 |
|
|
2018
Q2 | $28.2M | Buy |
165,664
+102,359
| +162% | +$15.9M | 0.05% | 385 |
|
|
2018
Q1 | $10.3M | Sell |
63,305
-134,703
| -68% | -$22M | 0.02% | 686 |
|
|
2017
Q4 | $29.7M | Buy |
198,008
+89,016
| +82% | +$13.2M | 0.05% | 336 |
|
|
2017
Q3 | $16.6M | Sell |
108,992
-30,900
| -22% | -$4.65M | 0.04% | 407 |
|
|
2017
Q2 | $18M | Sell |
139,892
-87,825
| -39% | -$10.6M | 0.05% | 345 |
|
|
2017
Q1 | $24.9M | Buy |
227,717
+118,127
| +108% | +$10.4M | 0.07% | 298 |
|
|
2016
Q4 | $8.07M | Sell |
109,590
-1,471
| -1% | -$120K | 0.04% | 418 |
|
|
2016
Q3 | $9.69M | Sell |
111,061
-39,801
| -26% | -$3.76M | 0.04% | 304 |
|
|
2016
Q2 | $13M | Buy |
150,862
+51,413
| +52% | +$4.44M | 0.06% | 239 |
|
|
2016
Q1 | $7.91M | Sell |
99,449
-46,801
| -32% | -$4.23M | 0.03% | 430 |
|
|
2015
Q4 | $18.4M | Buy |
146,250
+28,298
| +24% | +$3.42M | 0.04% | 319 |
|
|
2015
Q3 | $12.3M | Sell |
117,952
-118,403
| -50% | -$15.2M | 0.03% | 372 |
|
|
2015
Q2 | $29.2M | Buy |
236,355
+59,835
| +34% | +$7.54M | 0.08% | 141 |
|
|
2015
Q1 | $20.8M | Sell |
176,520
-53,404
| -23% | -$6.4M | 0.06% | 211 |
|
|
2014
Q4 | $27.3M | Sell |
229,924
-397,557
| -63% | -$44.8M | 0.1% | 179 |
|
|
2014
Q3 | $70.5M | Sell |
627,481
-50,434
| -7% | -$4.8M | 0.06% | 155 |
|
|
2014
Q2 | $64.2M | Buy |
677,915
+429,698
| +173% | +$30.1M | 0.06% | 138 |
|
|
2014
Q1 | $16.8M | Sell |
248,217
-155,736
| -39% | -$12.3M | 0.01% | 321 |
|
|
2013
Q4 | $30M | Buy |
403,953
+8,425
| +2% | +$587K | 0.02% | 221 |
|
|
2013
Q3 | $30M | Buy |
395,528
+233,607
| +144% | +$18.6M | 0.02% | 257 |
|
|
2013
Q2 | $12.9M | Buy |
+161,921
| New | +$11.9M | 0.01% | 295 |
|
Other funds holding VRTX
VCM
VPM
BNP Paribas Financial Markets's VRTX Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Vertex Pharmaceuticals (VRTX) stake by 37% in Q2 2026, selling an estimated $68M and leaving 262,258 shares worth $130M. The position accounts for 0.05% of the portfolio, ranked #359.
BNP Paribas Financial Markets first reported a position in VRTX in Q2 2013 and has held it in 53 quarters since. The position peaked at $285M in Q1 2025. 1,467 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- BNP Paribas Financial Markets held 262,258 shares of Vertex Pharmaceuticals worth $130M as of Q2 2026.
- BNP Paribas Financial Markets sold 153,367 Vertex Pharmaceuticals shares in Q2 2026, an estimated $68M.
- Vertex Pharmaceuticals made up 0.05% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #359 holding.
- BNP Paribas Financial Markets first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- BNP Paribas Financial Markets's Vertex Pharmaceuticals position peaked at $285M in Q1 2025.
- 1,467 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.